Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CCR6 | P51684 | 1/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24811995 | 0.95 | L3MBTL1 (0.68) | L3MBTL1MAPTRXFP1HDAC3HDAC1 | |
| SCHEMBL25801927 | 0.89 | L3MBTL1 (0.63) | L3MBTL1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL21068526 | 0.85 | L3MBTL1 (0.64) | L3MBTL1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL25801942 | 0.85 | L3MBTL1 (0.56) | L3MBTL1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL4344803 | 0.84 | L3MBTL1 (0.58) | L3MBTL1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL6378615 | 0.84 | HDAC1 (0.52) | L3MBTL1MAPTRXFP1HDAC3HDAC1 | |
| SCHEMBL16772764 | 0.83 | L3MBTL1 (0.57) | L3MBTL1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL6379732 | 0.83 | HDAC1 (0.53) | L3MBTL1MAPTRXFP1HDAC3HDAC1 | |
| SCHEMBL6987866 | 0.83 | L3MBTL1 (0.59) | L3MBTL1HDAC3HDAC1HDAC2NCOR2 | |
| SCHEMBL2579658 | 0.81 | CA14 (0.53) | L3MBTL1HDAC1HDAC2PPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736848-A1 | PHARMACEUTICAL COMPOSITION CONTAINING CATIONIC LIPID AND USE THEREOF | Shanghai Regenelead Therapies Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-20250064750-A1 | LIPID AND COMPOSITION USED FOR DELIVERY | JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) | 2025-02-27 | — | — | US | disclosed |
| WO-2025002352-A1 | PHARMACEUTICAL COMPOSITION CONTAINING CATIONIC LIPID AND USE THEREOF | 上海瑞宏迪医药有限公司 | 2025-01-02 | — | — | WO | disclosed |
| EP-4458806-A1 | LIPID AND COMPOSITION USED FOR DELIVERY | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2024-11-06 | — | — | EP | disclosed |
| WO-2023125738-A1 | LIPID AND COMPOSITION USED FOR DELIVERY | 江苏恒瑞医药股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023125738-A1 | LIPID AND COMPOSITION USED FOR DELIVERY | 江苏恒瑞医药股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064750-A1 | LIPID AND COMPOSITION USED FOR DELIVERY | H1-0, H1-2, H1-3 | L3MBTL1 511/4885MAPT 644/4885RXFP1 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.